Detalhe da pesquisa
1.
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.
Blood
; 139(26): 3722-3731, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439295
2.
Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University Experience.
Clin Lymphoma Myeloma Leuk
; 23(12): 874-881, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741763
3.
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther
; 29(7): 430-437, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031746
4.
Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma - The Oregon Health and Science University Experience.
Clin Lymphoma Myeloma Leuk
; 22(2): 105-112, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686447
5.
A long-wavelength fluorescent substrate for continuous fluorometric determination of alpha-mannosidase activity: resorufin alpha-D-mannopyranoside.
Anal Biochem
; 399(1): 7-12, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20026005